Evonik news

• 

  1 October 2025

  Evonik Awards Nobel Laureate Ben Feringa

  Ben Feringa, Nobel laureate, honored for his work in molecular machines and catalysis, highlighting the importance of academia-industry collaboration for sustainable solutions.
• 

  25 September 2025

  Evonik Lowers Outlook Amidst Economic Stagnation

  Evonik's Q3 EBITDA expected at €420-€460M, below Q2's €509M. Full-year forecast cut to €1.9B due to weak demand. Revenue and cash conversion also impacted.
• 

  25 September 2025

  Evonik and AMSilk Expand Partnership for Industrial-Scale Biotech Silk Production

  The partnership focuses on sustainable silk protein production for fashion and automotive use, enhancing output and efficiency while ensuring supply chain transparency and reduced costs.
• 

  23 September 2025

  Evonik Achieves EcoVadis Gold for Sustainability

  Ranked in the top 5% by EcoVadis, Evonik excels in sustainability, focusing on transparency, stakeholder collaboration, and sustainable supply chain management.
• 

  22 September 2025

  Evonik Introduces MaxiPure® Polysorbate 80 for Injectable Drugs

  MaxiPure® Polysorbate 80 offers ultra-high purity for injectable drugs, enhancing protein stability and solubilization, while ensuring regulatory compliance and formulation reliability.
• 

  18 September 2025

  Evonik Executive Board Update

  Maike Schuh exits Evonik; Christian Kullmann and Dr. Claus Rettig assume interim finance roles. Thomas Wessel's contract extended to 2028.

• 

  16 September 2025

  Evonik Introduces Clinical-Grade VECOLLAN® Collagen

  VECOLLAN® is now available for clinical trials, offering a non-animal collagen alternative for medical devices, enhancing safety and performance through sustainable production.
• 

  15 September 2025

  Evonik Introduces BoruCare® Capsin for Ruminants

  BoruCare® Capsin, a plant-based product, aids dairy cows with nutrient efficiency and heat stress, using a solvent-free process with chili peppers, debuting at SPACE 2025.
• 

  10 September 2025

  Evonik Advances Automated Life Cycle Assessments

  Evonik's TÜV-certified software automates LCAs, speeding up assessments and enhancing sustainability efforts across products, with full implementation by 2027.
• 

  9 September 2025

  Evonik and Ethris Partner on Nucleic Acid Delivery Platform

  The partnership aims to enhance nucleic acid delivery with a novel lipid nanoparticle platform, improving stability and targeting for therapies and vaccines.
• 

  2 September 2025

  Evonik Issues €500M Green Hybrid Bond

  The bond supports sustainable finance, aligns with Green Finance Framework, and funds Next Generation Solutions and Technologies. It was oversubscribed, attracting sustainability-focused investors.
• 

  2 September 2025

  Evonik Oxeno Launches Cloud-Based Planning Platform Upgrade

  Evonik Oxeno enhances its planning platform, boosting decision-making with cloud-based insights and streamlined workflows for improved supply chain resilience and strategic focus.
• 

  2 September 2025

  Evonik Launches Program for New Market Growth

  The program targets emerging markets, focusing on circular packaging, plastics recycling, and aerospace, leveraging Evonik's expertise for innovative solutions and growth opportunities.
• 

  28 August 2025

  Evonik Launches SYNEQT GmbH for Industrial Services

  SYNEQT will unify Marl and Wesseling's infrastructure services, aiming for climate-neutral, flexible industrial ecosystems and attracting new customers. Operations start January 1, 2026.
• 

  27 August 2025

  Evonik Opens Alkoxides Plant in Singapore

  The new plant boosts alkoxides production, enhancing supply security in Asia, supporting sustainability, and aligning with regional growth in biodiesel and pharmaceuticals.
• 

  1 August 2025

  Evonik Reports Q2 Demand Decline

  Q2 2025 saw a 12% EBITDA drop due to weak demand, currency effects, and divestments. Revenue fell 11%. Fewer shutdowns and new capacities expected to aid H2.
• 

  30 July 2025

  Evonik Shifts Epoxy Curing Agent Production to Renewable Electricity

  The transition cuts Scope 1 and 2 emissions by one third, supporting a 25% reduction by 2030 and climate neutrality by 2050.
• 

  16 July 2025

  Evonik Adopts Green Electricity for POLYVEST® in Marl

  Green electricity cuts emissions by 25% by 2030. POLYVEST® offers ISCC Plus certified eCO variants. Power Purchase Agreements start in 2025 to enhance sustainable energy sourcing.
• 

  1 July 2025

  Evonik Introduces Eco-Friendly Paper Bags for MetAMINO®

  New paper bags cut plastic use, align with EU recycling rules, and reduce CO2 footprint by 20%. Quality and shelf life remain unchanged. Transition starts in Antwerp, with more sites to follow.
• 

  12 September 2024

  €35M Investment Boosts Abolis Biotechnologies

  An international consortium's investment will expand biomanufacturing, accelerate R&D, and foster strategic partnerships in healthcare, cosmetics, and chemicals, driving sustainable biotech innovation.
• 

  3 September 2024

  Evonik Opens Sustainable Emollients Plant in Germany

  The new plant uses enzymatic processes to boost production of eco-friendly cosmetic emollients, reducing climate footprint and supporting sustainable beauty industry solutions.
• 

  29 May 2024

  Evonik Opens Sustainable Biosurfactant Plant in Slovakia

  The new facility produces industrial-scale rhamnolipid biosurfactants from renewable corn feedstocks, offering sustainable alternatives for various industries and reinforcing Evonik's biotechnology capabilities.
• 

  14 May 2024

  MOL Opens €1.3 Billion Polyol Complex in Hungary

  The new polyol complex in Hungary will produce materials for durable consumer goods using advanced technology, enhancing industrial competitiveness and creating long-term employment for nearly 300 people.
• 

  15 January 2024

  Evonik Expands HTPB Production in Marl

  The expanded plant will boost HTPB capacity by Q2 2024. The site benefits from integrated raw material supply and in-house R&D, enhancing service reliability and market position.
• 

  5 October 2023

  Evonik Expands Gas Separation Membrane Production in Austria

  New production lines for SEPURAN® membranes will be built in 2024, creating 50 jobs. The expansion supports green energy goals and aims to boost revenue from sustainable products by 2030.
• 

  3 July 2023

  Evonik Sells Lülsdorf Site to ICIG

  The sale of the Lülsdorf site and cyanuric chloride business to ICIG was completed on June 30. Over 600 employees and all production facilities are included, with extensive protective rights agreed.
• 

  17 April 2023

  Pilot Electrolyzer in Herne: Green Hydrogen for Wind Energy

  A pilot project in Herne aims to produce green hydrogen for wind turbine materials, reducing CO2 emissions. Funded by the German Federal Ministry, it tests new electrolysis technology until mid-2025.
• 

  14 April 2023

  Evonik Doubles Global VESTAMID® E Capacity in Shanghai and Marl

  The expansion in Shanghai and optimization in Marl will boost PEBA production, meeting high demand in athletic footwear and other industries, while enhancing sustainability with VESTAMID® eCO.
• 

  6 April 2023

  Evonik Sells Lülsdorf Site and Cyanuric Chloride Business to ICIG

  The sale includes over 600 employees and all production plants. The transaction awaits antitrust clearance and Evonik committee approval, with completion expected by mid-2023.
• 

  31 January 2023

  Evonik invests €25m in Wesseling methionine plant upgrade

  €25m investment enhances methionine production in Wesseling, improving efficiency and safety. Supports long-term supply to Antwerp hub, reinforcing global methionine network.